GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Achilles Therapeutics PLC (NAS:ACHL) » Definitions » Accumulated other comprehensive income (loss)

ACHL (Achilles Therapeutics) Accumulated other comprehensive income (loss) : $-7.94 Mil (As of Sep. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Achilles Therapeutics Accumulated other comprehensive income (loss)?

Accumulated other comprehensive income (loss) is the aggregate amount of gains or losses that are not part of retained earnings. Achilles Therapeutics's Accumulated other comprehensive income (loss) for the quarter that ended in Sep. 2024 was $-7.94 Mil.

Achilles Therapeutics's quarterly Accumulated other comprehensive income (loss) increased from Mar. 2024 ($-14.21 Mil) to Jun. 2024 ($-14.02 Mil) and increased from Jun. 2024 ($-14.02 Mil) to Sep. 2024 ($-7.94 Mil).

Achilles Therapeutics's annual Accumulated other comprehensive income (loss) declined from Dec. 2021 ($6.64 Mil) to Dec. 2022 ($-21.70 Mil) but then increased from Dec. 2022 ($-21.70 Mil) to Dec. 2023 ($-13.07 Mil).

Achilles Therapeutics Accumulated other comprehensive income (loss) Historical Data

The historical data trend for Achilles Therapeutics's Accumulated other comprehensive income (loss) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Achilles Therapeutics Accumulated other comprehensive income (loss) Chart

Achilles Therapeutics Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
Accumulated other comprehensive income (loss)
8.11 12.32 6.64 -21.70 -13.07

Achilles Therapeutics Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Accumulated other comprehensive income (loss) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -19.19 -13.07 -14.21 -14.02 -7.94

Achilles Therapeutics Accumulated other comprehensive income (loss) Calculation

Accumulated other comprehensive income (loss) is the aggregate amount of gains or losses that are not part of retained earnings.

Achilles Therapeutics Accumulated other comprehensive income (loss) Related Terms

Thank you for viewing the detailed overview of Achilles Therapeutics's Accumulated other comprehensive income (loss) provided by GuruFocus.com. Please click on the following links to see related term pages.

Achilles Therapeutics Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Achilles Therapeutics PLC (NAS:ACHL) » Definitions » Accumulated other comprehensive income (loss)
Comparable Companies
ALRN KZR OTLK RANI VYNE GANX CELU CASI OMGA ESLA VRTX ASX:CSL REGN XKRX:207940 XBRU:UCB XBRU:ARGX ALNY BNTX XKRX:068270 BGNE
Traded in Other Exchanges
698:Germany
Address
245 Hammersmith Road, London, GBR, W6 8PW
Website
https://www.achillestx.com
Achilles Therapeutics PLC is a biopharmaceutical company. It is developing AI-powered precision T-cell therapies targeting clonal neoantigens to treat solid tumors. The company has two ongoing trials, the CHIRON trial in patients with non-small-cell lung cancer and the THETIS trial in patients with recurrent or metastatic melanoma.